Table 1. Relative solubilization value (RSV) at various polymer concentrations. Ultr Amphipole – UltrasoluteTM Amphipole.
Polymer, % |
RSV |
Polymer, % |
RSV |
Polymer, % |
RSV |
Ultr Amph 18, 0.0625% |
62 |
DIBMA 10, 0.0625% |
1 |
AASTY 11-45, 0.0625% |
76 |
Ultr Amph 18, 0.125% |
37.5 |
DIBMA 10, 0.125% |
1 |
AASTY 11-45, 0.125% |
46.5 |
Ultr Amph 18, 0.250% |
30 |
DIBMA 10, 0.250% |
2 |
AASTY 11-45, 0.250% |
27.5 |
Ultr Amph 18, 0.500% |
13 |
DIBMA 10, 0.500% |
2 |
AASTY 11-45, 0.500% |
22.5 |
Ultr Amph 17, 0.0625% |
87 |
DIBMA12 , 0.0625% |
10 |
AASTY 6-55, 0.0625% |
46 |
Ultr Amph 17, 0.125% |
62.5 |
DIBMA12 , 0.125% |
10 |
AASTY 6-55, 0.125% |
72 |
Ultr Amph 17, 0.250% |
47 |
DIBMA12 , 0.250% |
9 |
AASTY 6-55, 0.250% |
41 |
Ultr Amph 17, 0.500% |
31.5 |
DIBMA12 , 0.500% |
13 |
AASTY 6-55, 0.500% |
25.5 |
SMALP 140, 0.0625% |
4 |
DIBMAGlicerol, 0.0625% |
16.5 |
AASTY 6-50, 0.0625% |
78.5 |
SMALP 140, 0.125% |
3.5 |
DIBMAGlicerol, 0.125% |
22 |
AASTY 6-50, 0.125% |
43 |
SMALP 140, 0.250% |
4 |
DIBMAGlicerol, 0.250% |
26.5 |
AASTY 6-50, 0.250% |
33 |
SMALP 140, 0.500% |
3.5 |
DIBMAGlicerol, 0.500% |
29.5 |
AASTY 6-50, 0.500% |
13 |
SMALP 200, 0.0625% |
9 |
DIBMAGlyco, 0.0625% |
3.5 |
AASTY 11-50, 0.0625% |
77 |
SMALP 200, 0.125% |
15 |
DIBMAGlyco, 0.125% |
28.5 |
AASTY 11-50, 0.125% |
54 |
SMALP 200, 0.250% |
8 |
DIBMAGlyco, 0.250% |
21.5 |
AASTY 11-50, 0.250% |
42 |
SMALP 200, 0.500% |
4.5 |
DIBMAGlyco, 0.500% |
11 |
AASTY 11-50, 0.500% |
23 |
SMALP 300, 0.0625% |
2 |
DIBMA Glucosamine, 0.0625% |
3 |
AASTY 11-55, 0.0625% |
5.5 |
SMALP 300, 0.125% |
26.5 |
DIBMA Glucosamine, 0.125% |
1 |
AASTY 11-55, 0.125% |
33.5 |
SMALP 300, 0.250% |
16 |
DIBMA Glucosamine, 0.250% |
1 |
AASTY 11-55, 0.250% |
25.5 |
SMALP 300, 0.500% |
7 |
DIBMA Glucosamine, 0.500% |
2 |
AASTY 11-55, 0.500% |
18 |
SMALP-140-I, 0.0625% |
11 |
AASTY 6-45, 0.0625% |
57 |
||
SMALP-140-I, 0.125% |
14 |
AASTY 6-45, 0.125% |
29 |
||
SMALP-140-I, 0.250% |
12 |
AASTY 6-45, 0.250% |
21.5 |
||
SMALP-140-I, 0.500% |
10.5 |
AASTY 6-45, 0.500% |
15.5 |